Ankle Strengthening in Athletes With Chronic Ankle Instability

NCT06801483 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2026-03-20

No results posted yet for this study

Summary

Chronic ankle instability (CAI) is a common complication following an ankle sprain, affecting joint stability and leading to decreased muscle strength and poor neuromuscular control. These symptoms can significantly impact athletes' sports performance. Rehabilitation training for CAI majorly involves strengthening or balance training. Few studies have discussed treatment plans that combine the above two training, and the effectiveness of combined training is similar to that of single training content. Due to the lack of machines to train ankle strength, thera-bands were often used for ankle strengthening. However, the resistance thera-bands provide is limited and may need more for athletes requiring high-intensity training. In recent years, a local company has developed a multiaxial ankle training system for machine-based ankle strengthening. This machine allows for training the ankle joint in various directions while sitting and can provide greater training resistance. As this machine has recently been developed and there is seldom evidence for its use in training, this project aims to discuss the effectiveness of using the ankle training machine in athletes with chronic ankle instability. This study will compare the differences in muscle strength, morphology, muscle material properties, balance ability, and functional performance of athletes after a six-week combined training program with thera-band or the multiaxial ankle training system for providing resistance. Thereby establishing a training plan for athletes suffering from chronic ankle instability.

Conditions

  • Chronic Ankle Instability, CAI
  • Athletes

Interventions

OTHER

Strengthening

All subjects will recieve an ankle muscle strenghening training program twice a week for six weeks.

Sponsors & Collaborators

  • National Science and Technology Council, Taiwan

    collaborator OTHER_GOV
  • China Medical University Hospital

    lead OTHER

Principal Investigators

  • Chia-Ming Chang, Ph.D. · China Medical University, China

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
28 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2024-12-20
Completion
2026-01-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06801483 on ClinicalTrials.gov